NCT00666770View on ClinicalTrials.gov

A Polysomnographic Study of Single-Dose Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance

PHASE3CompletedINTERVENTIONAL
Enrollment

309

Participants

Timeline

Start Date

October 31, 2004

Study Completion Date

November 30, 2004

Conditions
Transient Insomnia
Interventions
DRUG

Gabapentin

Gabapentin 250 mg oral capsule 30 minutes prior to bedtime

DRUG

Gabapentin

Gabapentin 500 mg oral capsule 30 minutes prior to bedtime

DRUG

Placebo

Matched placebo 30 minutes prior to bedtime

Trial Locations (5)

10025

Pfizer Investigational Site, New York

66211

Pfizer Investigational Site, Overland Park

66212

Pfizer Investigational Site, Overland Park

91206

Pfizer Investigational Site, Glendale

92123

Pfizer Investigational Site, San Diego

All Listed Sponsors
lead

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

INDUSTRY

NCT00666770 - A Polysomnographic Study of Single-Dose Gabapentin in Transient Insomnia Induced by a Sleep Phase Advance | Biotech Hunter | Biotech Hunter